These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 25525048

  • 1. Laboratory assessment of the anticoagulant activity of dabigatran.
    Kyriakou E, Ikonomidis I, Stylos D, Bonovas S, Papadakis I, Nikolopoulos GK, Kokoris S, Kalantzis D, Economopoulou C, Kopterides P, Lekakis J, Tsantes AE.
    Clin Appl Thromb Hemost; 2015 Jul; 21(5):434-45. PubMed ID: 25525048
    [Abstract] [Full Text] [Related]

  • 2. Impact of dabigatran on platelet function and fibrinolysis.
    Tsantes AE, Kyriakou E, Bonovas S, Chondrogianni M, Zompola C, Liantinioti C, Simitsi A, Katsanos AH, Atta M, Ikonomidis I, Kapsimali V, Kopterides P, Tsivgoulis G.
    J Neurol Sci; 2015 Oct 15; 357(1-2):204-8. PubMed ID: 26219486
    [Abstract] [Full Text] [Related]

  • 3. Comparative Assessment of the Anticoagulant Activity of Rivaroxaban and Dabigatran in Patients With Nonvalvular Atrial Fibrillation: A Noninterventional Study.
    Tsantes AE, Kyriakou E, Ikonomidis I, Katogiannis K, Papadakis I, Douramani P, Kopterides P, Kapsimali V, Lekakis J, Tsangaris I, Bonovas S.
    Medicine (Baltimore); 2016 Apr 15; 95(14):e3037. PubMed ID: 27057830
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Monitoring of Oral Thrombin Inhibitor].
    Matsuno K, Usami T, Hatuse M, Shimizu C.
    Rinsho Byori; 2014 Oct 15; 62(10):958-64. PubMed ID: 27526541
    [Abstract] [Full Text] [Related]

  • 7. A novel coagulation parameter monitoring bleeding tendency of Chinese nonvalvular atrial fibrillation patients prescribing dabigatran etexilate.
    Wang H, Zhou Y, Rong G, Lu L, Zhang J.
    Blood Coagul Fibrinolysis; 2016 Jul 15; 27(5):563-7. PubMed ID: 26881855
    [Abstract] [Full Text] [Related]

  • 8. From laboratory to clinical practice: Dabigatran effects on thrombin generation and coagulation in patient samples.
    Helin TA, Lemponen M, Hjemdahl P, Rönquist-Nii Y, Lassila R, Joutsi-Korhonen L.
    Thromb Res; 2015 Jul 15; 136(1):154-60. PubMed ID: 25981140
    [Abstract] [Full Text] [Related]

  • 9. Reversal of dabigatran anticoagulation ex vivo: Porcine study comparing prothrombin complex concentrates and idarucizumab.
    Honickel M, Treutler S, van Ryn J, Tillmann S, Rossaint R, Grottke O.
    Thromb Haemost; 2015 Apr 15; 113(4):728-40. PubMed ID: 25567155
    [Abstract] [Full Text] [Related]

  • 10. Whole blood coagulation assays ROTEM and T-TAS to monitor dabigatran treatment.
    Taune V, Wallén H, Ågren A, Gryfelt G, Sjövik C, Wintler AM, Malmström RE, Wikman A, Skeppholm M.
    Thromb Res; 2017 May 15; 153():76-82. PubMed ID: 28347811
    [Abstract] [Full Text] [Related]

  • 11. The effect of dabigatran on thrombin generation and coagulation assays in rabbit and human plasma.
    Zhang C, Zhang P, Li H, Han L, Zhang L, Zhang L, Yang X.
    Thromb Res; 2018 May 15; 165():38-43. PubMed ID: 29558660
    [Abstract] [Full Text] [Related]

  • 12. Impact of Dabigatran Treatment on Rotation Thromboelastometry.
    Sokol J, Nehaj F, Ivankova J, Mokan M, Zolkova J, Lisa L, Linekova L, Mokan M, Stasko J.
    Clin Appl Thromb Hemost; 2021 May 15; 27():1076029620983902. PubMed ID: 33523711
    [Abstract] [Full Text] [Related]

  • 13. Estimation of dabigatran plasma concentrations in the perioperative setting. An ex vivo study using dedicated coagulation assays.
    Douxfils J, Lessire S, Dincq AS, Hjemdahl P, Rönquist-Nii Y, Pohanka A, Gourdin M, Chatelain B, Dogné JM, Mullier F.
    Thromb Haemost; 2015 Apr 15; 113(4):862-9. PubMed ID: 25519251
    [Abstract] [Full Text] [Related]

  • 14. The effect of total hip/knee replacement surgery and prophylactic dabigatran on thrombin generation and coagulation parameters.
    Green L, Lawrie AS, Patel R, Stephens RC, Mackie IJ, Chitolie A, Haddad FS, Machin SJ.
    Thromb Res; 2012 Nov 15; 130(5):775-9. PubMed ID: 22245224
    [Abstract] [Full Text] [Related]

  • 15. The modification of the thrombin generation test for the clinical assessment of dabigatran etexilate efficiency.
    Gribkova IV, Lipets EN, Rekhtina IG, Bernakevich AI, Ayusheev DB, Ovsepyan RA, Ataullakhanov FI, Sinauridze EI.
    Sci Rep; 2016 Jul 05; 6():29242. PubMed ID: 27377013
    [Abstract] [Full Text] [Related]

  • 16. Dabigatran: is there a role for coagulation assays in guiding therapy?
    Brunetti L, Bandali F.
    Ann Pharmacother; 2013 Jun 05; 47(6):828-40. PubMed ID: 23673530
    [Abstract] [Full Text] [Related]

  • 17. Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate.
    Douxfils J, Mullier F, Robert S, Chatelain C, Chatelain B, Dogné JM.
    Thromb Haemost; 2012 May 05; 107(5):985-97. PubMed ID: 22438031
    [Abstract] [Full Text] [Related]

  • 18. In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate.
    Wienen W, Stassen JM, Priepke H, Ries UJ, Hauel N.
    Thromb Haemost; 2007 Jul 05; 98(1):155-62. PubMed ID: 17598008
    [Abstract] [Full Text] [Related]

  • 19. Rapid determination of anticoagulating effects of dabigatran in whole blood with rotational thromboelastometry and a thrombin-based trigger.
    Taune V, Skeppholm M, Ågren A, Gryfelt G, Malmström RE, Wikman A, Van Ryn J, Wallén H.
    J Thromb Haemost; 2018 Dec 05; 16(12):2462-2470. PubMed ID: 30288934
    [Abstract] [Full Text] [Related]

  • 20. Assessing the anticoagulant effect of dabigatran in children: an in vitro study.
    Dietrich K, Stang L, van Ryn J, Mitchell LG.
    Thromb Res; 2015 Apr 05; 135(4):630-5. PubMed ID: 25715905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.